ZNF397 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.337600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.121200E-01
Normal-vs-Stage2
3.265400E-01
Normal-vs-Stage3
2.096600E-01
Normal-vs-Stage4
2.950600E-01
Stage1-vs-Stage2
8.093800E-02
Stage1-vs-Stage3
2.978500E-02
Stage1-vs-Stage4
6.725000E-01
Stage2-vs-Stage3
6.089900E-02
Stage2-vs-Stage4
4.449600E-01
Stage3-vs-Stage4
5.499700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.394400E-01
Normal-vs-AfricanAmerican
3.578800E-01
Normal-vs-Asian
2.492800E-01
Caucasian-vs-AfricanAmerican
8.485200E-01
Caucasian-vs-Asian
4.680100E-02
AfricanAmerican-vs-Asian
5.702400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.294800E-01
Normal-vs-Female
3.397000E-01
Male-vs-Female
7.026800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.913400E-01
Normal-vs-Age(41-60Yrs)
3.822000E-01
Normal-vs-Age(61-80Yrs)
3.116400E-01
Normal-vs-Age(81-100Yrs)
3.224200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.661000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.323600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.936600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.752340E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.622400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.851400E-01
Normal-vs-Daily Drinker
2.859800E-01
Normal-vs-Weekly Drinker
2.807200E-01
Normal-vs-Occasional Drinker
3.825600E-01
Normal-vs-Social Drinker
4.646400E-01
Non Drinker-vs-Daily Drinker
9.949200E-01
Non Drinker-vs-Weekly Drinker
8.748000E-01
Non Drinker-vs-Occasional Drinker
5.344300E-02
Non Drinker-vs-Social Drinker
2.083600E-02
Daily Drinker-vs-Weekly Drinker
8.812400E-01
Daily Drinker-vs-Occasional Drinker
8.334300E-02
Daily Drinker-vs-Social Drinker
1.316380E-02
Weekly Drinker-vs-Occasional Drinker
1.018420E-01
Weekly Drinker-vs-Social Drinker
2.376000E-02
Occasional Drinker-vs-Social Drinker
4.008000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.027900E-02
Normal-vs-Grade 2
1.058250E-02
Normal-vs-Grade 3
4.595500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.224200E-01
Grade 1-vs-Grade 3
4.726200E-01
Grade 1-vs-Grade 4
3.027900E-02
Grade 2-vs-Grade 3
8.565600E-01
Grade 2-vs-Grade 4
1.058250E-02
Grade 3-vs-Grade 4
4.595500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.973800E-01
Normal-vs-NonDiabetic
3.236200E-01
Diabetic-vs-NonDiabetic
3.324200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.919600E-01
Normal-vs-NoPancreatitis
3.191800E-01
Pancreatitis-vs-NoPancreatitis
5.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.530800E-01
Normal-vs-N1
3.243200E-01
N0-vs-N1
4.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.700600E-01
Normal-vs-TP53-NonMutant
4.324000E-01
TP53-Mutant-vs-TP53-NonMutant
4.12260000000053E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
